176 related articles for article (PubMed ID: 38012744)
21. Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells.
Lim DA; Huang YC; Swigut T; Mirick AL; Garcia-Verdugo JM; Wysocka J; Ernst P; Alvarez-Buylla A
Nature; 2009 Mar; 458(7237):529-33. PubMed ID: 19212323
[TBL] [Abstract][Full Text] [Related]
22. MLL1 inhibition reduces IgM levels in Waldenström macroglobulinemia.
Karbalivand M; Almada LL; Ansell SM; Fernandez-Zapico ME; Elsawa SF
Leuk Res; 2022 May; 116():106841. PubMed ID: 35462170
[TBL] [Abstract][Full Text] [Related]
23. Set1 and MLL1/2 Target Distinct Sets of Functionally Different Genomic Loci In Vivo.
Duncan EM; Chitsazan AD; Seidel CW; Sánchez Alvarado A
Cell Rep; 2015 Dec; 13(12):2741-55. PubMed ID: 26711341
[TBL] [Abstract][Full Text] [Related]
24. Pro isomerization in MLL1 PHD3-bromo cassette connects H3K4me readout to CyP33 and HDAC-mediated repression.
Wang Z; Song J; Milne TA; Wang GG; Li H; Allis CD; Patel DJ
Cell; 2010 Jun; 141(7):1183-94. PubMed ID: 20541251
[TBL] [Abstract][Full Text] [Related]
25. Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment.
Zhou C; Zhang Y; Dai J; Zhou M; Liu M; Wang Y; Chen XZ; Tang J
Sci Rep; 2016 Feb; 6():22066. PubMed ID: 26902498
[TBL] [Abstract][Full Text] [Related]
26. Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance.
Huo H; Magro PG; Pietsch EC; Patel BB; Scotto KW
Cancer Res; 2010 Nov; 70(21):8726-35. PubMed ID: 20861184
[TBL] [Abstract][Full Text] [Related]
27. Higher blood MLL1 mRNA and BDNF promoter IV on histone H3K4me3 levels in patients with schizophrenia.
Huang TL; Lin CC; Chen RF; Lee CT
Psychiatry Res; 2016 Sep; 243():207-9. PubMed ID: 27419650
[TBL] [Abstract][Full Text] [Related]
28. MLL1 is regulated by KSHV LANA and is important for virus latency.
Tan M; Li S; Juillard F; Chitas R; Custódio TF; Xue H; Szymula A; Sun Q; Liu B; Álvarez ÁL; Chen S; Huang J; Simas JP; McVey CE; Kaye KM
Nucleic Acids Res; 2021 Dec; 49(22):12895-12911. PubMed ID: 34850113
[TBL] [Abstract][Full Text] [Related]
29. CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex.
Schmidt L; Heyes E; Scheiblecker L; Eder T; Volpe G; Frampton J; Nerlov C; Valent P; Grembecka J; Grebien F
Leukemia; 2019 Jul; 33(7):1608-1619. PubMed ID: 30679799
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation regulates discrimination of enhancers from promoters through a H3K4me1-H3K4me3 seesaw mechanism.
Sharifi-Zarchi A; Gerovska D; Adachi K; Totonchi M; Pezeshk H; Taft RJ; Schöler HR; Chitsaz H; Sadeghi M; Baharvand H; Araúzo-Bravo MJ
BMC Genomics; 2017 Dec; 18(1):964. PubMed ID: 29233090
[TBL] [Abstract][Full Text] [Related]
31. Establishment of active chromatin structure at enhancer elements by mixed-lineage leukemia 1 to initiate estrogen-dependent gene expression.
Jeong KW; Andreu-Vieyra C; You JS; Jones PA; Stallcup MR
Nucleic Acids Res; 2014 Feb; 42(4):2245-56. PubMed ID: 24288367
[TBL] [Abstract][Full Text] [Related]
32. Aberrant activation of CYR61 enhancers in colorectal cancer development.
Xie L; Song X; Lin H; Chen Z; Li Q; Guo T; Xu T; Su T; Xu M; Chang X; Wang LK; Liang B; Huang D
J Exp Clin Cancer Res; 2019 May; 38(1):213. PubMed ID: 31118064
[TBL] [Abstract][Full Text] [Related]
33. The STAT4/MLL1 Epigenetic Axis Regulates the Antimicrobial Functions of Murine Macrophages.
Carson WF; Cavassani KA; Soares EM; Hirai S; Kittan NA; Schaller MA; Scola MM; Joshi A; Matsukawa A; Aronoff DM; Johnson CN; Dou Y; Gallagher KA; Kunkel SL
J Immunol; 2017 Sep; 199(5):1865-1874. PubMed ID: 28733487
[TBL] [Abstract][Full Text] [Related]
34. Cyp33 binds AU-rich RNA motifs via an extended interface that competitively disrupts the gene repressive Cyp33-MLL1 interaction in vitro.
Lloyd NR; Wuttke DS
PLoS One; 2021; 16(2):e0237956. PubMed ID: 33606679
[TBL] [Abstract][Full Text] [Related]
35. Mixed-lineage leukaemia 1 contributes to endometrial stromal cells progesterone responsiveness during decidualization.
Xiong Y; Wang Y; Ma L; Zhang Y; Qu X; Huang L; Wen X; Liu H; Zhang M; Zhang Y
J Cell Mol Med; 2021 Jan; 25(1):297-308. PubMed ID: 33201593
[TBL] [Abstract][Full Text] [Related]
36. The Development of Inhibitors Targeting the Mixed Lineage Leukemia 1 (MLL1)-WD Repeat Domain 5 Protein (WDR5) Protein- Protein Interaction.
Ye X; Chen G; Jin J; Zhang B; Wang Y; Cai Z; Ye F
Curr Med Chem; 2020; 27(33):5530-5542. PubMed ID: 31132972
[TBL] [Abstract][Full Text] [Related]
37. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.
Kaikkonen MU; Spann NJ; Heinz S; Romanoski CE; Allison KA; Stender JD; Chun HB; Tough DF; Prinjha RK; Benner C; Glass CK
Mol Cell; 2013 Aug; 51(3):310-25. PubMed ID: 23932714
[TBL] [Abstract][Full Text] [Related]
38. Super-Enhancers and Broad H3K4me3 Domains Form Complex Gene Regulatory Circuits Involving Chromatin Interactions.
Cao F; Fang Y; Tan HK; Goh Y; Choy JYH; Koh BTH; Hao Tan J; Bertin N; Ramadass A; Hunter E; Green J; Salter M; Akoulitchev A; Wang W; Chng WJ; Tenen DG; Fullwood MJ
Sci Rep; 2017 May; 7(1):2186. PubMed ID: 28526829
[TBL] [Abstract][Full Text] [Related]
39. Ectopic HOTTIP expression induces noncanonical transactivation pathways to promote growth and invasiveness in pancreatic ductal adenocarcinoma.
Wong CH; Li CH; He Q; Chan SL; Tong JH; To KF; Lin LZ; Chen Y
Cancer Lett; 2020 May; 477():1-9. PubMed ID: 32120024
[TBL] [Abstract][Full Text] [Related]
40. The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness.
Grinat J; Heuberger J; Vidal RO; Goveas N; Kosel F; Berenguer-Llergo A; Kranz A; Wulf-Goldenberg A; Behrens D; Melcher B; Sauer S; Vieth M; Batlle E; Stewart AF; Birchmeier W
Nat Commun; 2020 Dec; 11(1):6422. PubMed ID: 33349639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
